XML 65 R53.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Legal Proceedings (Details) $ in Millions | 1 Months Ended | 3 Months Ended | 9 Months Ended
--- | --- | --- | ---
May 31, 2014 claim | Oct. 01, 2017 USD ($) patient claimant | Oct. 02, 2016 USD ($) | Oct. 01, 2017 USD ($) patents patient claimant | Oct. 02, 2016 USD ($)
ASR |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |
Product Liability Contingency Number Of Claimants |  | 2,000 |  | 2,000 |
Pinnacle Acetabular Cup System |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |
Product Liability Contingency Number Of Claimants |  | 9,900 |  | 9,900 |
Pelvic Meshes |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |
Product Liability Contingency Number Of Claimants |  | 54,300 |  | 54,300 |
Risperdal |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |
Product Liability Contingency Number Of Claimants |  | 13,900 |  | 13,900 |
Xarelto |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |
Product Liability Contingency Number Of Claimants |  | 21,400 |  | 21,400 |
Talc |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |
Product Liability Contingency Number Of Claimants |  | 5,500 |  | 5,500 |
Invokana |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |
Product Liability Contingency Number Of Claimants |  | 1,100 |  | 1,100 |
Pending Litigation | Talc |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |
Loss Contingency, New Claims Filed, Number | claim | 2 |  |  |  |
Investigative Demands [Member] |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |
Litigation Settlement, Expense | $ |  |  |  | $ 4 |
DePuy ASR U.S. | settled litigation |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |
Number of patients in settlement | patient |  | 10,000 |  | 10,000 |
Medinol Ltd. [Member] |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |
Loss Contingency, Patents Allegedly Infringed, Number | patents |  |  |  | 4 |
Medical Devices [Member] |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |
Litigation Settlement, Expense | $ |  | $ 100 | $ 100 | $ 500 | $ 700

X
- Definition Legal Proceeding Textuals Abstract. + References No definition available. + Details
Name: | jnj_LegalProceedingTextualsAbstract
Namespace Prefix: | jnj_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of patients in settlement + References No definition available. + Details
Name: | jnj_Numberofpatientsinsettlement
Namespace Prefix: | jnj_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Product liability contingency number of claimant. + References No definition available. + Details
Name: | jnj_ProductLiabilityContingencyNumberOfClaimant
Namespace Prefix: | jnj_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The total number of new claims filed pertaining to a loss contingency during the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14435-108349 + Details
Name: | us-gaap_LossContingencyNewClaimsFiledNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of another entity's patents that the entity has allegedly infringed. + References No definition available. + Details
Name: | us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ProductOrServiceAxis=jnj_AsrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=jnj_PinnacleAcetabularCupSystemMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=jnj_PelvicMeshesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=jnj_RisperdalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=jnj_XareltoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=jnj_TalcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=jnj_InvokanaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationCaseAxis=jnj_InvestigativeDemandsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationCaseAxis=jnj_DePuyASRU.S.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationCaseAxis=jnj_MedinolLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |